Development of hyperdiploidy starts at an early age and takes a decade to complete
Abstract
Abstract Nearly half of patients with multiple myeloma (MM) have hyperdiploidy (HMM) at diagnosis. Although HMM occurs early, the mutational processes before and after hyperdiploidy are still unclear. Here, we used 72 whole-genome sequencing samples from patients with HMM and identified pre- and post-HMM mutations to define the chronology of the development of hyperdiploidy. An MM cell accumulated a median of 0.56 mutations per megabase before HMM, and for every clonal pre-HMM mutation, 1.21 mutations per megabase accumulated after HMM. This analysis using mutations before and after hyperdiploidy shows that hyperdiploidy happens after somatic hypermutation. Prehyperdiploidy mutations are activation-induced cytidine deaminase and age/clock-like signature driven, whereas posthyperdiploidy mutations are from DNA damage and APOBEC. Interestingly, the first hyperdiploidy event occurred within the first 3 decades of life and took a decade to complete. Copy number changes affecting chromosomes 15 and 19 occurred first. Finally, mutations before initiating event affected chromosomes at different rates, whereas post–initiating event mutational processes affect each chromosome equally.
Article Details
Authors (11)
Mehmet K. Samur
Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, Massachusetts, United States
Anil Aktas Samur
Dana Farber Cancer Institution, Boston, Massachusetts, United States
Parth Shah
Joseph S. Park
3Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
Mariateresa Fulciniti
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Masood Shammas
5Dana Farbar (Harvard) Cancer Institute, Molecular Oncology, Boston, United States
Jill Corre
Unité Génomique du Myélome, Hôpital Universitaire de Toulouse Oncopole, Université de Toulouse, Toulouse, France
Kenneth C. Anderson
Giovanni Parmigiani
Hervé Avet-Loiseau
Unité Génomique du Myélome, Hôpital Universitaire de Toulouse Oncopole, Université de Toulouse, Toulouse, France
Nikhil C. Munshi